Guangxi Wuzhou Zhongheng Group Co.,Ltd
|
1.9 Billion CNY
|
85.937%
|
Yabao Pharmaceutical Group Co., Ltd
|
1.66 Billion CNY
|
83.92%
|
ZhuZhou QianJin Pharmaceutical Co.,Ltd
|
1.74 Billion CNY
|
84.69%
|
Tasly Pharmaceutical Group Co., Ltd
|
5.66 Billion CNY
|
95.272%
|
Jiangsu Kanion Pharmaceutical Co.,Ltd.
|
3.61 Billion CNY
|
92.592%
|
Hubei Jumpcan Pharmaceutical Co., Ltd.
|
7.74 Billion CNY
|
96.545%
|
Shandong Lukang Pharmaceutical Co.,Ltd.
|
1.46 Billion CNY
|
81.68%
|
North China Pharmaceutical Company Ltd.
|
3.21 Billion CNY
|
91.672%
|
Zhejiang Shengda Bio-Pharm Co., Ltd.
|
74.18 Million CNY
|
-260.732%
|
Heilongjiang ZBD Pharmaceutical Co., Ltd.
|
1.32 Billion CNY
|
79.839%
|
Dali Pharmaceuticalco.,Ltd
|
36.29 Million CNY
|
-637.273%
|
Guobang Pharma Ltd.
|
1.2 Billion CNY
|
77.863%
|
Changchun BCHT Biotechnology Co.
|
1.6 Billion CNY
|
83.288%
|
China Animal Husbandry Industry Co., Ltd.
|
1.06 Billion CNY
|
74.956%
|
Tianjin Tianyao Pharmaceuticals Co., Ltd.
|
1.65 Billion CNY
|
83.832%
|
Kangmei Pharmaceutical Co., Ltd.
|
715.07 Million CNY
|
62.576%
|
Zhejiang Starry Pharmaceutical Co.,Ltd.
|
464.77 Million CNY
|
42.423%
|
Shandong Buchang Pharmaceuticals Co., Ltd.
|
8.7 Billion CNY
|
96.925%
|
Shanghai Haoyuan Chemexpress Co., Ltd.
|
759.03 Million CNY
|
64.744%
|
Zhejiang Huahai Pharmaceutical Co., Ltd.
|
4.83 Billion CNY
|
94.466%
|
Harbin Pharmaceutical Group Co., Ltd.
|
3.76 Billion CNY
|
92.896%
|
Zhejiang Medicine Co., Ltd.
|
2.52 Billion CNY
|
89.399%
|
HPGC Renmintongtai Pharmaceutical Corporation
|
986.11 Million CNY
|
72.863%
|
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
|
3.59 Billion CNY
|
92.546%
|
Lionco Pharmaceutical Group Co.,Ltd.
|
86.95 Million CNY
|
-207.752%
|
Humanwell Healthcare (Group) Co.,Ltd.
|
10.65 Billion CNY
|
97.488%
|
Ginwa Enterprise (Group) Inc.
|
431.65 Million CNY
|
38.004%
|
KPC Pharmaceuticals, Inc.
|
3.33 Billion CNY
|
91.976%
|
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
|
361.03 Million CNY
|
25.879%
|
Jiangsu Jibeier Pharmaceutical Co., Ltd.
|
765.77 Million CNY
|
65.054%
|
Ningbo Menovo Pharmaceutical Co., Ltd.
|
342.7 Million CNY
|
21.914%
|
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
|
2.07 Billion CNY
|
87.134%
|
Nanjing Well Pharmaceutical Group Co.,Ltd.
|
312.86 Million CNY
|
14.467%
|
Henan Lingrui Pharmaceutical Co., Ltd.
|
2.42 Billion CNY
|
88.974%
|
Joincare Pharmaceutical Group Industry Co.,Ltd.
|
9.79 Billion CNY
|
97.268%
|
China Resources Double-Crane Pharmaceutical Co.,Ltd.
|
5.61 Billion CNY
|
95.234%
|
Chongqing Taiji Industry(Group) Co.,Ltd
|
7.13 Billion CNY
|
96.251%
|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
|
13.54 Billion CNY
|
98.025%
|
China National Medicines Corporation Ltd.
|
3.85 Billion CNY
|
93.053%
|
Shenzhen Chipscreen Biosciences Co., Ltd.
|
433.54 Million CNY
|
38.275%
|
Guizhou Yibai Pharmaceutical Co., Ltd.
|
1.84 Billion CNY
|
85.473%
|
Zhongzhu Healthcare Holding Co.,Ltd
|
-114.92 Million CNY
|
332.849%
|
Beijing Tongrentang Co., Ltd
|
8.3 Billion CNY
|
96.777%
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
|
735.98 Million CNY
|
63.64%
|
Jianmin Pharmaceutical Group Co.,Ltd.
|
1.88 Billion CNY
|
85.777%
|
Tibet Weixinkang Medicine Co., Ltd.
|
672.1 Million CNY
|
60.184%
|
CanSino Biologics Inc.
|
-876.01 Million CNY
|
130.548%
|
Zhejiang Hisun Pharmaceutical Co., Ltd.
|
4.18 Billion CNY
|
93.604%
|
Shanghai Jiaoda Onlly Co.,Ltd
|
62.19 Million CNY
|
-330.262%
|
Jiang Zhong Pharmaceutical Co.,Ltd
|
2.74 Billion CNY
|
90.261%
|
Mayinglong Pharmaceutical Group Co., LTD.
|
1.3 Billion CNY
|
79.529%
|
Cisen Pharmaceutical Co., Ltd.
|
2.54 Billion CNY
|
89.504%
|
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
|
431.02 Million CNY
|
37.914%
|
Hunan Warrant Pharmaceutical Co.,Ltd
|
928.23 Million CNY
|
71.17%
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
19.8 Billion CNY
|
98.649%
|
Hunan Fangsheng Pharmaceutical Co., Ltd.
|
1.1 Billion CNY
|
75.81%
|
Shaanxi Kanghui Pharmaceutical Co., Ltd.
|
183.75 Million CNY
|
-45.636%
|
Henan Taloph Pharmaceutical Stock Co.,Ltd
|
538.56 Million CNY
|
50.311%
|
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
|
659.13 Million CNY
|
59.4%
|
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
|
528.34 Million CNY
|
49.35%
|
Shanghai Shyndec Pharmaceutical Co., Ltd.
|
4.39 Billion CNY
|
93.91%
|
Shanghai Yizhong Pharmaceutical Co., Ltd.
|
336.2 Million CNY
|
20.403%
|
Tibet Rhodiola Pharmaceutical Holding Co.
|
2.94 Billion CNY
|
90.901%
|
Sichuan Huiyu Pharmaceutical Co., Ltd.
|
787.59 Million CNY
|
66.022%
|
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
|
1.04 Billion CNY
|
74.367%
|